Immunocore Holdings Ltd (IMCR)
US$ 34.691.11%
Price Chart
Key Statistics
Market Cap
$ 1.76B
P/E Ratio
0.00
Revenue (TTM)
$ 333.58M
Volume
199.47K
52W High
$ 41.54
52W Low
$ 23.15
Dividend Yield
0.00%
Beta
0.83
Technicals
50-Day MA
32.6152
200-Day MA
31.0163
52 Week High
41.54
52 Week Low
23.15
About IMCR
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KI.
Employees
493
Headquarters
Abingdon, United Kingdom
CEO
Dr. Bahija Jallal Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg